Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?

@inproceedings{Farup2016FaecalSF,
  title={Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?},
  author={Per G Farup and Knut Rudi and Knut A. Hestad},
  booktitle={BMC gastroenterology},
  year={2016}
}
BACKGROUND The diagnosis of irritable bowel syndrome (IBS) relies on symptom-based criteria. A valid and reliable biomarker that could confirm the diagnosis is desirable. This study evaluated the properties of faecal short-chain fatty acids (SCFA) as diagnostic biomarkers for IBS. METHODS Twenty-five subjects with IBS and 25 controls were included in this explanatory case-control study. Stool samples were analysed for SCFA (acetic acid, propionic acid, butyric acid, isobutyric acid, valeric… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 18 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Biomarkers of Irritable Bowel Syndrome

Journal of neurogastroenterology and motility • 2017
View 2 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 36 references

The role of short-chain fatty acids in health and disease.

Advances in immunology • 2014
View 4 Excerpts
Highly Influenced